MUNICH, Dec 29 (Reuters) - Siemens AG is

reviewing its majority stake in medical technology subsidiary

Siemens Healthineers,, the German technology group's

Chief Financial Officer Ralf Thomas told the Handelsblatt

newspaper.

The synergies with the manufacturer of MRI machines and

laboratory systems are not great enough to justify a capital

commitment of 45 billion euros ($46.91 billion), Thomas told

Handelsblatt, referring to how much Siemens' 75% equity stake is

worth.

"We are evaluating the economic opportunities for Siemens AG

in the healthcare sector. We will then derive from this how

instrumental Healthineers is as an investment. And then we will

draw a conclusion from that," he said, adding that the results

will be presented at a capital markets day at the end of 2025.

Siemens AG spun off the Erlangen, Germany-based subsidiary

in 2018 and floated it on the stock exchange. Until now, Siemens

had maintained it would keep the majority stake in Siemens

Healthineers.

However, Thomas recently held out the prospect of selling

around 5% in the foreseeable future to finance the takeover of

U.S. software company Altair.

Thomas said he remained committed to the Mobility train

division, which investors have repeatedly called to be spun off.

"The business is in good hands with us. I don't see any need

for us to part with it at the moment," he told Handelsblatt.

($1 = 0.9592 euros)